SCHEMBL29136922

SCHEMBL29136922

CNc1cn2cc(C3CC3)ccc2n1

nearest known ligand 0.38

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
METTL3 Q86U44 1/20 0.38
LRRK2 Q5S007 5/20 0.34
KLKB1 P03952 8/20 0.34
MAP3K5 Q99683 2/20 0.34
ABL1 P00519 1/20 0.33
DGAT1 O75907 1/20 0.33
MAP4K1 Q92918 1/20 0.33
SLC18A3 Q16572 1/20 0.33
KDM4E B2RXH2 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29136812 0.98 METTL3 (0.37) METTL3LRRK2KLKB1MAP3K5ABL1
SCHEMBL21845499 0.80 METTL3 (0.36) METTL3LRRK2KLKB1DGAT1MAP4K1
SCHEMBL23452838 0.78 METTL3 (0.35) METTL3LRRK2KLKB1DGAT1
SCHEMBL21359015 0.77 METTL3 (0.35) METTL3KLKB1DGAT1KDM4E
SCHEMBL27030315 0.77 KDM4E (0.60) METTL3KLKB1KDM4ETP53
SCHEMBL28790408 0.77 KLKB1 (0.50) METTL3KLKB1
Hydrochloric Acid SCHEMBL27030313 0.76 KDM4E (0.58) METTL3KLKB1KDM4ETP53
SCHEMBL24834491 0.75 NPC1 (0.52) MAP3K5KDM4ETP53
SCHEMBL24729704 0.75 METTL3 (0.44) METTL3KLKB1KDM4ETP53
SCHEMBL29137005 0.75 METTL3 (0.37) METTL3KLKB1DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117396473-A Imidazopyridinyl inhibitors of plasma kallikrein 武田药品工业株式会社 2024-01-12 CN disclosed
CN-117396474-A Plasma kallikrein inhibitors 武田药品工业株式会社 2024-01-12 CN disclosed
CN-117355521-A Heteroaryl inhibitors of plasma kallikrein 武田药品工业株式会社 2024-01-05 CN disclosed
CN-117355523-A Polycyclic inhibitors of plasma kallikrein 武田药品工业株式会社 2024-01-05 CN disclosed